Page last updated: 2024-08-22

n-methylaspartate and Esophageal Neoplasms

n-methylaspartate has been researched along with Esophageal Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Gao, Y; Ge, B; Liu, C; Wang, J; Wang, Q; Wang, T; Wei, B; Xu, L; Zhou, Y	1

Other Studies

1 other study(ies) available for n-methylaspartate and Esophageal Neoplasms

Article	Year
LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β-Catenin and NF-κB signaling pathway. Cancer science, 2022, Volume: 113, Issue:10 Topics: beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Esophageal Neoplasms; Fibronectins; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Membrane Glycoproteins; N-Methylaspartate; Nerve Tissue Proteins; NF-kappa B; Receptors, N-Methyl-D-Aspartate; Wnt Signaling Pathway	2022

Article

Year

LRFN2 binding to NMDAR inhibits the progress of ESCC via regulating the Wnt/β-Catenin and NF-κB signaling pathway.

Cancer science, 2022, Volume: 113, Issue:10

Topics: beta Catenin; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclin D1; Esophageal Neoplasms; Fibronectins; Gene Expression Regulation, Neoplastic; Glycogen Synthase Kinase 3 beta; Humans; Membrane Glycoproteins; N-Methylaspartate; Nerve Tissue Proteins; NF-kappa B; Receptors, N-Methyl-D-Aspartate; Wnt Signaling Pathway

2022